Patent details
EP2222299 Title: USE OF LEVOCABASTINE FOR MODULATING GENERATION OF PRO-INFLAMMATORY CYTOKINES
Basic Information
- Publication number:
- EP2222299
- PCT Application Number:
- PCT/US/2008/081328
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP088526728
- PCT Publication Number:
- WO/2009/067317
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF LEVOCABASTINE FOR MODULATING GENERATION OF PRO-INFLAMMATORY CYTOKINES
- French Title of Invention:
- COMPOSITIONS ET PROCEDES DE MODULATION DE LA PRODUCTION DE CYTOKINES PRO-INFLAMMATOIRES
- German Title of Invention:
- VERWENDUNG VON LEVOCABASTIN ZUR MODULIERUNG DER ERZEUGUNG VON PROINFLAMMATORISCHEN ZYTOKINEN
- SPC Number:
Dates
- Filing date:
- 27/10/2008
- Grant date:
- 23/11/2011
- EP Publication Date:
- 23/11/2011
- PCT Publication Date:
- 28/05/2009
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 01/09/2010
- EP B1 Publication Date:
- 23/11/2011
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 27/10/2012
- Expiration date:
- 27/10/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 27/10/2008
- Name:
- Bausch & Lomb Incorporated
- Address:
- One Bausch & Lomb Place, Rochester, NY 14604-2701, United States (US)
Inventor
1
- Name:
- ZHANG Jinzhong
- Address:
- United States (US)
2
- Name:
- BUCOLO Claudio
- Address:
- Italy (IT)
3
- Name:
- WARD Keith, Wayne
- Address:
- United States (US)
Priority
- Priority Number:
- 988913 P
- Priority Date:
- 19/11/2007
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/445;
| Filing date | Document type | Number of pages |
|---|